News About: Pharm. Industry
Domestic Unavailability of Taxol 100mg Explained
It is reported that a recent decision by the Seoul National University Hospital (SNUH) to remove BMS Korea's anticancer drug Taxol from the list of prescription medications was due to an unmet request for Taxol availa...
We are unable to publish February 24th English Yakup reports
Due to reasons beyond our circumstances, we are unable to publish February 24th English Yakup reports. We sincerely aplogize for this matter.
Pharmaceutical Firms Focus on Medical Clinic Market for Potential Sales
The nation's leading pharmaceutical firms are expanding their marketing and promotion strategies to target the medical clinics that are once overlooked, for these firms traditionally give their main efforts on the gen...
Retail Pharmacies Increasingly Provide OTC Products as Service Items
The stagnant over-the-counter (OTC) product sales for an extended period is creating more instances where the retail pharmacies are treating these products as service items, selling without significant profit margins ...
Listed Pharmaceutical Stocks Attract More Investment
The overall performance of pharmaceutical firms in the domestic stock markets shows its strong growth momentum, outpacing the past market performance indicators at more than double digit growths.
According to the m...
OTC Makers Consider Different Pricing Strategies to Boost Revenue
As the domestic over-the-counter (OTC) product sales are continuing to decline for an extended period of time, the pharmaceutical firms are implementing different marketing and pricing strategies to gain higher sales ...
KSE-Listed Firms Show Strong Financial Results for Three Quarters
The 3rd quarter year-to-date (YTD) financial results for KSE-listed pharmaceutical firms, with their fiscal year ending March 2005, collectively show over 12 percent growth in revenue, propelled by aggressive ma...
KPMA Aims to Promote Global Competitiveness for Domestic Manufacturers
The Korea Pharmaceutical Manufacturer Association (KPMA) held a board meeting last week to finalize the association's main operating objectives for the current year, under an overall initiative to gain a competitive e...
Topamax Approved for Migraine Headache Prevention
The Korea Food and Drug Administration (KFDA) has recently approved Topamax (active ingredient: topiramate), an anti-seizure medication marketed by Janssen Korea, for prevention of migraine headaches in adults.
Th...
Lifecord Stat-Korea Makes Partnership Agreement with MDS Pharma Services
Lifecord Stat-Korea (LSK), a domestic CRO (contract research organization) company, recently made a business partnership agreement with MDS Pharma Services, a global provider of drug discovery and development solution...
